Assmenat addition of autologous platelet-rich plasma in premature ovarian failur effect rejuvenalization

Effect of autologous platelet-rich plasma on ovarian frejuvenalization

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20151123025202N2

Enrollment

Registered

2019-11-10

Start date

2019-03-21

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

premature ovarian failur. Primary ovarian failure

Interventions

Intervention 1: Intervention group: In addition to receiving routine medication 5 ml of PRP after adding calcium as an activator is injected into the ovary with sterile conditions. Intervention 2: Co

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Women with amenorrhea before the age of 40

Exclusion criteria

Exclusion criteria: Amenorrhea due to a specific illness

Design outcomes

Primary

Measure	Time frame
Treatment of infertility. Timepoint: At intervention time(Base), 2, 6 and 12 months after intervention. Method of measurement: Hormonal testing and ultrasound.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbbas Moradi

Hamedan University of Medical Sciences

a.moradi@umsha.ac.ir+98 81 3823 5480

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026